Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows

PM Images Bristol-Myers Squibb (NYSE:BMY) fell to $39.35 in July, and since then, has appreciated by 26.56% to $49.80. Despite climbing more than 25% over the past 2 months, I still believe there is a tremendous amount of value left to be unlocked from shares BMY after their Q2 earnings provided some validation to my investment thesis. Shares of BMY still yield 4.8% and trade at less than 10 times next year's earnings. With rate cuts on the way and CME Group predicting that there is a 100% chance that the r ...